pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Obesity · news · pharmadog
← back to Obesity
News mentioning Obesity
737
stories
2h
STAT+: Big drugmakers tell House committee they will halt clinical trials at some hospitals in China
stat
9h
Lilly starts work on Pennsylvania obesity plant; ITM, AtomVie strike supply deal
endpoints
12h
STAT+: Pharmalittle: We’re reading about a Merck AI deal, China and the pharma supply chain, and more
stat
1d
STAT+: NIH to move last group of its research chimps to a sanctuary
stat
1d
‘Selling and marketing snake oil’: The debate over compounded GLP-1s
biopharma dive
1d
Novo’s consumer push gains momentum with Wegovy pill, CagriSema on deck
endpoints
1d
STAT+: FDA discloses reasons for rejecting Summit drug
stat
1d
STAT+: Pharmalittle: We’re reading about Overton FDA nomination being yanked, a Merck setback, and more
stat
1d
Pfizer launches into autoimmune CAR T with China's Starna in up to $2.6B deal
biospace
1d
Summit’s rejection, Isomorphic’s record $5B raise, obesity and Alzheimer’s in the spotlight
biospace
2d
STAT+: Flagship opens biotech-creation outpost in the U.K.
stat
2d
U.S. loses measles elimination status, marking embarrassing stain on its public health record
stat
2d
STAT+: ‘Medicare for More’ gains traction
stat
2d
STAT+: Pharmalittle: We’re reading about a Roche breast cancer pill, obesity drugs in children, and more
stat
3d
STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for Roche
stat
3d
STAT+: Newer GLP-1 drugs to combat obesity may be the next global battleground over access to medicines, expert warns
stat
3d
STAT+: Suing Joe the Plumber and Microsoft, and diminishing raises
stat
3d
J&J pays $2.2B upfront for Ollin, taps Blackstone to fund eye disease trial
biospace
3d
Novo’s CagriSema drives more than 20% weight loss at lower doses
biospace
3d
ObesityWeek 2026: Wave outlines case for body composition–based trial design
biospace
3d
STAT+: Helus’ psychedelic drug improved depression in study but faces safety questions
stat
3d
Seawolf launches with $100M to make non-viral gene therapies
endpoints
3d
BeOne, Hengrui top list of China’s most powerful drugmakers
stat
4d
STAT+: FDA rejects lung cancer treatment ivonescimab from Summit Therapeutics
stat
6d
STAT+: Doctors have questions about the Watchman. Boston Scientific has a sales pitch.
stat
6d
STAT+: HHS plans funding for research into ibogaine for PTSD
stat
6d
The future of heart drug research in the wake of study setbacks
stat
6d
Biopharma pushes beyond GLP-1s, weight loss at ObesityWeek 2026
biospace
6d
Gubra CEO gets the quick hook; Ex-HHS official Brett Giroir takes over at cancer biotech
endpoints
6d
Across the U.S., homegrown experiments aim to save kids from their phones
stat
← prev
page 1 of 25
next →